EDGAR Filing Documents for 0001193805-17-000177

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

SEC Accession No. 0001193805-17-000177

Filing Date

2017-02-14

Accepted

2017-02-14 08:04:46

Documents

Group Members

DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT III, L.P.DEERFIELD MGMT, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq	Description	Document	Type	Size
1		e615727_sc13ga-akari.htm	SC 13G/A	366815
	Complete submission text file	0001193805-17-000177.txt		368503

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017

Business Address

Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Subject) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: SC 13G/A | Act: 34 | File No.: 005-87614 | Film No.: 17602535
SIC: 2834 Pharmaceutical Preparations